Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Shepherd

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
International Journal of Epidemiology|February 1, 1992
The probability of progression to AIDS in a cohort of male sexual contacts of men with HIV diseaseV T Farewell, R A Coates, M M Fanning, et al.
Seminars in Oncology|September 5, 1998
Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug deliveryR P Abratt, A Sandler, L Crinò, et al.
Leukemia & Lymphoma|January 1, 1995
HIV-associated lymphoma of the gastrointestinal tract: the University of Toronto AIDS-Lymphoma Study Group experienceK R Imrie, C A Sawka, G Kutas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2000
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheresJ E Dancey, F A Shepherd, K Paul, et al.
Seminars in Oncology|February 1, 1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancerF A Shepherd, W K Evans, P E Goss, et al.
The Journal of Infectious Diseases|September 1, 1985
Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndromeS E Read, B R Williams, R A Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancerA M Horgan, P A Bradbury, E Amir, et al.
Radiology|September 1, 1989
Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheresS Houle, T K Yip, F A Shepherd, et al.
Cancer Research|April 1, 1984
Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancerD M Russell, M Shike, E B Marliss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancerU Sagman, R Feld, W K Evans, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
International Journal of Epidemiology|February 1, 1992
The probability of progression to AIDS in a cohort of male sexual contacts of men with HIV diseaseV T Farewell, R A Coates, M M Fanning, et al.
Seminars in Oncology|September 5, 1998
Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug deliveryR P Abratt, A Sandler, L Crinò, et al.
Leukemia & Lymphoma|January 1, 1995
HIV-associated lymphoma of the gastrointestinal tract: the University of Toronto AIDS-Lymphoma Study Group experienceK R Imrie, C A Sawka, G Kutas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2000
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheresJ E Dancey, F A Shepherd, K Paul, et al.
Seminars in Oncology|February 1, 1992
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancerF A Shepherd, W K Evans, P E Goss, et al.
The Journal of Infectious Diseases|September 1, 1985
Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndromeS E Read, B R Williams, R A Coates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancerA M Horgan, P A Bradbury, E Amir, et al.
Radiology|September 1, 1989
Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheresS Houle, T K Yip, F A Shepherd, et al.
Cancer Research|April 1, 1984
Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancerD M Russell, M Shike, E B Marliss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancerU Sagman, R Feld, W K Evans, et al.
Pageof 18